Reuters logo
BRIEF-FDA advises drug manufacturers on Burkholderia cepacia complex contamination risk
May 22, 2017 / 5:26 PM / 7 months ago

BRIEF-FDA advises drug manufacturers on Burkholderia cepacia complex contamination risk

May 22 (Reuters) - U.S. FDA:

* FDA advises drug manufacturers that Burkholderia cepacia complex poses a contamination risk in non-sterile, water-based drug product

* Advises manufacturers of non-sterile, water-based drug products there have been recent recalls due to Burkholderia cepacia complex contamination Source text - (bit.ly/2pmyLF9)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below